Fibrates [orch, phsu]
Essential [qlco]
Part [spco]
Dyslipidaemia [dsyn]
Arsenal [orch, phsu]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Residual [qlco]
Risk Reduction [inbe]
Currently [tmco]
World [popg]
Face [blor]
Epidemic [phpr]
Several [qnco]
condition [dsyn]
Obesity [dsyn]
Metabolic syndrome [dsyn]
Lipid [lipd]
Profile [lbpr]
Patients [podg]
Metabolic syndrome [dsyn]
Characterized [acty]
Concurrent [tmco]
Presence [topp]
Qualitative [qlco]
Quantitative [qnco]
Lipoprotein [aapp, bacs]
Abnormalities [cgab]
low [qlco]
Levels [qlco]
increased triglycerides [fndg]
Prevalence [qnco]
LDL particle [celc]
Smaller [qlco]
Dense [qlco]
Normal [qlco]
This [euka]
Lipid [lipd]
Phenotype [orga]
Defined [cnce]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Evidence [ftcn]
Components [mnob]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
risk factors [qnco]
Cardiovascular Diseases [dsyn]
Optimal [qlco]
reduction [npop]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Comprehensive [qlco]
Management [ocac]
Atherogenesis [patf]
Dyslipidemias [dsyn]
depend [medd]
Presence [topp]
Efficacy [qlco]
Lipid [lipd]
Modulating [spco]
Agent [chvf]
Statin [orch, phsu]
Based [ftcn]
reduction [npop]
Most [qnco]
Class [inpr]
Medications [phsu]
Atherogenesis [patf]
Dyslipidemias [dsyn]
Fibrates [orch, phsu]
Clinical [qlco]
Point [qnco]
View [spco]
Available [ftcn]
randomized [resa]
Control [grup]
Trial [resa]
effects [qlco]
Major [qlco]
Fibrates [orch, phsu]
Gemfibrosil [lipd, phsu]
Fenofibrate [orch, phsu]
Bezafibrate [orch, phsu]
Highly significant [qlco]
Patients [podg]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Main [qlco]
Determinant [ftcn]
Overall [inpr]
Result [ftcn]
Trial [resa]
Dependent [qlco]
included [ftcn]
Appropriate [qlco]
Patients [podg]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Meta-Analysis [inpr]
Dyslipidaemia [dsyn]
subgroups [virs]
Patients [podg]
Relative Risk [qnco]
reduction [npop]
cardiovascular events [fndg]
Observed [ftcn]
Compared [acty]
Non [ftcn]
reduction [npop]
Without [qlco]
Dyslipidaemia [dsyn]
Different [qlco]
Fibrates [orch, phsu]
Somewhat [inpr]
Different [qlco]
Spectrum [qnco]
effects [qlco]
Currently [tmco]
Only [qnco]
Fenofibrate [orch, phsu]
investigated [ftcn]
To [qlco]
effective [qlco]
Reducing [qlco]
Microvascular [ftcn]
Complications [patf]
Diabetes [dsyn]
Bezafibrate [orch, phsu]
Reduced [qlco]
Severity [qlco]
Intermittent Claudication [dsyn]
Cardinal [bird]
Bezafibrate [orch, phsu]
Fibrates [orch, phsu]
effects [qlco]
glucose metabolism [moft]
Insulin Resistance [patf]
Bezafibrate [orch, phsu]
Only [qnco]
Available [ftcn]
Pan [mamm]
Alpha [inpr]
Beta [plnt]
Gamma [npop]
PPAR [aapp, rcpt]
Balanced [ftcn]
Bezafibrate [orch, phsu]
Decrease [qlco]
Blood glucose level [lbtr]
Insulin Resistance [patf]
Incidence [qnco]
Compared [acty]
placebo [topp]
Fibrates [orch, phsu]
Major [qlco]
Fibrates [orch, phsu]
Bezafibrate [orch, phsu]
APPEAR [qlco]
To [qlco]
Strong [qlco]
Fenofibrate [orch, phsu]
Weak [sosy]
Effect [qlco]
Current [tmco]
therapeutic use [topp]
Statins [orch, phsu]
Patients [podg]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
High Risk [qlco]
coronary [bpoc]
Events [evnt]
Statin [orch, phsu]
therapy [ftcn]
Not [ftcn]
Residual [qlco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Associated [qlco]
low hdl [fndg]
high triglycerides [fndg]
Compared [acty]
Statin [orch, phsu]
effective [qlco]
Level [qlco]
Plaque [dsyn]
Stabilisation [topp]
Association [menp]
Statin [orch, phsu]
Major [qlco]
IMPACT [gngm]
Triglycerides [bacs, lipd]
LDL Particle Size [lbpr]
Specific [qlco]
Case [ftcn]
Bezafibrate [orch, phsu]
One [qnco]
Adverse Effect [fndg]
Pro [aapp, bacs]
diabetic [fndg]
Statins [orch, phsu]
Muscle Pain [sosy]
Myositis [dsyn]
Issue [fndg]
Statin [orch, phsu]
treatment [ftcn]
Interaction [ftcn]
APPEAR [qlco]
To [qlco]
Occur [acty]
Great extent [qlco]
Gemfibrosil [lipd, phsu]
Administered [ftcn]
Bezafibrate [orch, phsu]
Fenofibrate [orch, phsu]
To [qlco]
Safeties [hcpp]
Better [qlco]
Combined therapy [topp]
Statin [orch, phsu]
More [ftcn]
effective [qlco]
Comprehensive [qlco]
Lipid [lipd]
Control [grup]
???lead [elii, hops]
Additional [ftcn]
CARDIOVASCULAR [bdsy]
Risk Reduction [inbe]
Suggest [idcn]
Fenofibrate [orch, phsu]
Following [tmco]
accord [socb]
Lipid [lipd]
Study Subgroup [qnco]
Analysis [lbpr]
Bezafibrate [orch, phsu]
One [qnco]
Small [qnco]
randomized [resa]
Study [mnob]
Multiple [qnco]
OBSERVATIONAL [resa]
Data [idcn]
Appropriate [qlco]
Patients [podg]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Fibrates [orch, phsu]
Combined [qlco]
Statins [orch, phsu]
Associated [qlco]
Reduced [qlco]
Risk [qlco]
cardiovascular events [fndg]
Fibrates [orch, phsu]
Currently [tmco]
Part [spco]
Dyslipidaemia [dsyn]
Arsenal [orch, phsu]
Patients [podg]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
